Overview of Myeloid Cell Line

As blood cells develop, different “families” branch off from blood-forming stem cells. The myeloid cell line represents one such family. Cells in the myeloid cell line are those that arise from myeloid progenitor cells, and will eventually become the specific adult blood cells, shown here:

Thus, each of the cell types above represents the final product or the result of growing up in the myeloid family.

It's the myeloid cell line that is affected in "myeloid malignancies" such as acute myelogenous leukemia (AML), which has the highest total number of diagnoses each year, and chronic myelogenous leukemia (CML), which accounts for about 6,660 new diagnoses in a year in the United States.

Blood Test
TEK IMAGE/SCIENCE PHOTO LIBRARY / Getty Images

Context

Red cells, white blood cells, and platelets all have fixed life expectancies, and they are replaced continuously. Blood-forming stem cells—residing mostly in the bone marrow in adults—multiply and produce different populations or lineages of cells.

All mature blood cells can trace their lineage back to a single cell type, the multipotent hematopoietic stem cell (HSC), something akin to the “Adam and Eve” of all blood cells. These stem cells divide, both to make replacements for themselves and to form “progenitor cells.” Among the descendants of the HSC, then, are different kinds of progenitor cells: there is a common lymphoid progenitor and a common myeloid progenitor. This fork in the road between lymphoid and myeloid lineages is a major one. Each progenitor can give rise to its own distinct families of blood cells. White blood cells known as lymphocytes develop from lymphoid progenitors, while different white blood cells, red blood cells, and platelets develop from the myeloid progenitors. Cells of the myeloid line normally make up about 85 percent of marrow cells, in total.

Myeloid Malignancies

According to the American Cancer Society, most patients with acute myeloid leukemia (AML) have too many immature white cells in their blood, and not enough red blood cells or platelets. Many of the white blood cells may be myeloblasts—often just called blasts—which are immature blood-forming cells that are not normally found out in the circulating blood. These immature cells don’t work like normal, mature white blood cells.

Most patients with chronic myeloid leukemia (CML) have too many white blood cells with many early, immature cells. Some of these immature white cells may be also blasts but usually are present in smaller number than in AML. Sometimes CML patients may also have low numbers of red blood cells or blood platelets.

In both AML and CML, counts of blood cells can be suggestive of leukemia, but a definitive diagnosis requires bone marrow biopsy and aspirate and other tests.

Frequently Asked Questions

  • What are myeloid cells?

    A myeloid cell is a type of blood cell that originates in the bone marrow. As a myeloid cell matures into an adult blood cell, it will take on a specific role as a basophil, eosinophil, erythrocyte, macrophage, monocyte, neutrophil, or platelet. 

  • Are myeloid cells cancerous?

    On their own, myeloid cells do not indicate cancer. However, myeloid cells can develop cancer known as myeloid malignancies.

    For example, acute myeloid leukemia (AML) is a blood and bone marrow cancer. Caused by a DNA mutation in the stem cells, AML occurs when the bone marrow makes a large number of abnormal blood cells.

  • What is the difference between myeloid and lymphoid cells?

    Myeloid and lymphoid cells are two types of progenitor cells. Progenitor cells are cells that came from stem cells and change into specific types of cells. 

    Myeloid cells are derived from the bone marrow and become red blood cells and blood platelets.

    Lymphoid cells come from the lymphatic system and become lymphocytes and natural killer cells. 

Was this page helpful?
4 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Granatowicz A, Piatek CI, Moschiano E, El-hemaidi I, Armitage JD, Akhtari M. An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians. Korean J Fam Med. 2015;36(5):197-202. doi:10.4082/kjfm.2015.36.5.197

  2. NIH Stem Cell Information. Hematopoietic Stem Cells.

  3. American Cancer Society. Tests for Acute Myeloid Leukemia (AML).

  4. American Cancer Society. Phases of chronic myeloid leukemia.

Additional Reading
  • American Cancer Society. How is acute myeloid leukemia diagnosed? 

  • Eaves CJ. Hematopoietic stem cells: concepts, definitions, and the new reality. Blood; 125(17):2605-2613.

  • Jagannathan-Bogdan M, Zon LI. Hematopoiesis. Development (Cambridge, England); 140(12):2463-2467.

  • Krumsiek J, Marr C, Schroeder T, et al. Hierarchical Differentiation of Myeloid Progenitors Is Encoded in the Transcription Factor Network. PLoS One; 6(8):e22649.

  • Orkin SH, Zon LI. Hematopoiesis: An Evolving Paradigm for Stem Cell Biology. Cell; 132(4):631-644.

  • Williams, L. "Comprehensive Review of Hematopoiesis and Immunology: Implications for Hematopoietic Stem Cell Transplant Recipients" in Ezzone, S. Hematopoietic Stem Cell Transplantation: A Manual for Nursing Practice Oncology Nursing Society: Pittsburgh, PA (pp.1- 12).